TY  - JOUR
AU  - Hardy, Timothy
AU  - Wonders, Kristy
AU  - Younes, Ramy
AU  - Aithal, Guruprasad P
AU  - Aller, Rocio
AU  - Allison, Michael
AU  - Bedossa, Pierre
AU  - Betsou, Fay
AU  - Boursier, Jerome
AU  - Brosnan, M Julia
AU  - Burt, Alastair
AU  - Cobbold, Jeremy
AU  - Cortez-Pinto, Helena
AU  - Day, Chris P
AU  - Dufour, Jean-Francois
AU  - Ekstedt, Mattias
AU  - Francque, Sven
AU  - Harrison, Stephen
AU  - Miele, Luca
AU  - Nasr, Patrik
AU  - Papatheodoridis, George
AU  - Petta, Salvatore
AU  - Tiniakos, Dina
AU  - Torstenson, Richard
AU  - Valenti, Luca
AU  - Holleboom, Adriaan G
AU  - Yki-Jarvinen, Hannele
AU  - Geier, Andreas
AU  - Romero-Gomez, Manuel
AU  - Ratziu, Vlad
AU  - Bugianesi, Elisabetta
AU  - Schattenberg, Jörn M
AU  - Anstee, Quentin M
AU  - LITMUS Consortium
PY  - 2020
DO  - 10.1016/j.cct.2020.106175
UR  - http://hdl.handle.net/10668/16403
T2  - Contemporary clinical trials
AB  - Non-Alcoholic Fatty Liver Disease (NAFLD), a progressive liver disease that is closely associated with obesity, type 2 diabetes, hypertension and dyslipidaemia, represents an increasing global public health challenge. There is significant variability...
LA  - en
KW  - Biomarker
KW  - Cirrhosis
KW  - NAFLD
KW  - NASH
KW  - Cohort Studies
KW  - Diabetes Mellitus, Type 2
KW  - Humans
KW  - Liver
KW  - Liver Cirrhosis
KW  - Liver Neoplasms
KW  - Longitudinal Studies
KW  - Non-alcoholic Fatty Liver Disease
KW  - Registries
TI  - The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease.
TY  - research article
VL  - 98
ER  -